Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
Sign Up to like & getrecommendations! Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0171596
Abstract: Objectives Two nucleos(t)ide reverse-transcriptase inhibitors (NRTIs) plus 1 non-NRTI (nNRTI) remain the preferred or alternative combination antiretroviral therapy (cART) for antiretroviral-naive HIV-positive patients in Taiwan. The three most commonly used nNRTIs are nevirapine (NVP), efavirenz… read more here.
Keywords: nucleoside reverse; hepatotoxicity; reverse transcriptase; hiv positive ... See more keywords
Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging
Sign Up to like & getrecommendations! Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.24928
Abstract: Background The development of skin rashes is the most common adverse event observed in cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitors such as erlotinib. However, the pharmacological evidence has not been fully… read more here.
Keywords: mass spectrometry; skin; normal skin; distribution erlotinib ... See more keywords
Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review
Sign Up to like & getrecommendations! Published in 2020 at "Biology"
DOI: 10.3390/biology9120449
Abstract: Simple Summary Patients diagnosed with COVID-19 and concomitant skin rashes have been frequently reported. We summarized the cases described to date, including only patients with positive RT-PCR testing from nasopharyngeal swabs. Six hundred and fifty-five… read more here.
Keywords: covid patients; cutaneous manifestations; systematic review; positive pcr ... See more keywords